UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Inc
MSTR
|
+$1.21B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$855M |
| 3 |
Microsoft
MSFT
|
+$810M |
| 4 |
Advanced Micro Devices
AMD
|
+$805M |
| 5 |
Boeing
BA
|
+$739M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$561M |
| 2 |
Amneal Pharmaceuticals
AMRX
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$161M |
| 4 |
Unity
U
|
+$158M |
| 5 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.49% |
| 2 | Financials | 9.06% |
| 3 | Consumer Discretionary | 7.01% |
| 4 | Healthcare | 6.25% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
YMAB
6176
DELISTED
Y-mAbs Therapeutics
YMAB
| $305K | ﹤0.01% |
38,932
-5,654
| -13% | -$68.9K |
|
6177
Oil-Dri
ODC
$1.34B
| $304K | ﹤0.01% |
6,946
-55,178
| -89% | -$2.02M |
|
6178
CNB Financial Corp
CCNE
$1.03B
| $304K | ﹤0.01% |
12,220
+1,119
| +10% | +$29.2K |
|
6179
T. Rowe Price Total Return ETF
TOTR
$574M
| $302K | ﹤0.01% |
+7,553
| New | +$307K |
|
6180
FTC Solar
FTCI
$44.9M
| $301K | ﹤0.01% |
54,624
+50,781
| +1,321% | +$232K |
|
6181
iMGP DBi Managed Futures Strategy ETF
DBMF
$4.13B
| $301K | ﹤0.01% |
11,500
+3,500
| +44% | +$95.3K |
|
|
NEUE
6182
DELISTED
NeueHealth
NEUE
| $301K | ﹤0.01% |
40,539
+36,753
| +971% | +$195K |
|
6183
Cheche Group
CCG
$35.2M
| $301K | ﹤0.01% |
9,654
+2,475
| +34% | +$72.9K |
|
|
CRDL
6184
Cardiol Therapeutics
CRDL
$164M
| $301K | ﹤0.01% |
234,818
+232,168
| +8,761% | +$391K |
|
6185
Cato Corp
CATO
$66.1M
| $300K | ﹤0.01% |
76,952
+61,987
| +414% | +$302K |
|
|
FRGE
6186
DELISTED
Forge Global Holdings
FRGE
| $299K | ﹤0.01% |
21,401
+17,761
| +488% | +$293K |
|
6187
Roundhill Ball Metaverse ETF
METV
$219M
| $299K | ﹤0.01% |
20,766
-55,928
| -73% | -$788K |
|
|
GAP
6188
CALL
The Gap Inc
GAP
$7.37B
| $298K | ﹤0.01% |
12,600
-20,080
| -61% | -$458K |
|
6189
Roundhill Video Games ETF
NERD
$15.7M
| $298K | ﹤0.01% |
15,069
+380
| +3% | +$7.3K |
|
6190
KraneShares California Carbon Allowance Strategy ETF
KCCA
$116M
| $297K | ﹤0.01% |
15,129
-14,981
| -50% | -$317K |
|
6191
VEON
VEON
$3.95B
| $297K | ﹤0.01% |
7,397
+1,326
| +22% | +$44K |
|
|
PGACU
6192
Pantages Capital Acquisition Corp Unit
PGACU
| $295K | ﹤0.01% |
+29,451
| New | +$295K |
|
6193
BNY Mellon US Mid Cap Core Equity ETF
BKMC
$671M
| $295K | ﹤0.01% |
8,703
+3,057
| +54% | +$107K |
|
6194
PUT
Albertsons Companies
ACI
$5.83B
| $295K | ﹤0.01% |
15,000
+7,500
| +100% | +$142K |
|
6195
Eltek
ELTK
$59.5M
| $294K | ﹤0.01% |
26,626
-1,228
| -4% | -$13.3K |
|
6196
Farmers & Merchants Bancorp
FMAO
$481M
| $294K | ﹤0.01% |
9,991
+1,359
| +16% | +$40.6K |
|
6197
Invesco Trust for Investment Grade New York Municipals
VTN
$168M
| $293K | ﹤0.01% |
27,940
+408
| +1% | +$4.58K |
|
|
CIO
6198
DELISTED
City Office REIT
CIO
| $292K | ﹤0.01% |
52,965
-2,739
| -5% | -$15K |
|
|
BINI
6199
DELISTED
Bollinger Innovations
BINI
| – | – |
0
| – | – |
|
6200
Veru
VERU
$37.4M
| $292K | ﹤0.01% |
44,857
+38,414
| +596% | +$285K |
|
Similar funds
UBS Group's Q4 2024 Portfolio in Review
As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,382 new positions and adding to 6,044 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.
- UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
- UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
- UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
- UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
- UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
- UBS Group opened 1,382 new positions and closed 943 in Q4 2024.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.
Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.